×
About 1,108 results

ALLMedicine™ Gastrointestinal Tumors Center

Research & Reviews  533 results

Tuberous Sclerosis Complex with rare associated findings in the gastrointestinal system...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7682061
BMC Gastroenterology; Reis LB, Konzen D et. al.

Nov 23rd, 2020 - Tuberous Sclerosis Complex (TSC) is a complex and heterogeneous genetic disease that has well-established clinical diagnostic criteria. These criteria do not include gastrointestinal tumors. We report a 45-year-old patient with a clinical and mole...

Prediction of technically difficult endoscopic submucosal dissection for large superfic...
https://doi.org/10.1016/j.gie.2020.11.012
Gastrointestinal Endoscopy; Li B, Shi Q et. al.

Nov 22nd, 2020 - Endoscopic submucosal dissection (ESD) is a promising technique for removing superficial gastrointestinal tumors, but ESD is technically difficult. The aims of this study were to establish a clinical score model for grading technically difficult c...

Imaging Features of Neurofibromatosis Type 1 in the Abdomen and Pelvis.
https://doi.org/10.2214/AJR.19.22283
AJR. American Journal of Roentgenology; Zulfiqar M, Lin M et. al.

Nov 19th, 2020 - OBJECTIVE. Loss of the neurofibromatosis type 1 (NF1) tumor suppressor protein causes uninhibited activation of the RAS oncogene, which leads to tumorigenesis in patients with NF1. This case-based review discusses imaging manifestations of NF1 in ...

Prevalence, diagnosis, and treatment of primary hepatic gastrointestinal stromal tumors.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7596635
World Journal of Gastroenterology; Qian XH, Yan YC et. al.

Nov 12th, 2020 - Gastrointestinal stromal tumors (GIST), which is the most common mesenchymal tumor of the digestive tract, account for 1%-3% of gastrointestinal tumors. Primary stromal tumors outside the gastrointestinal tract are collectively referred to as extr...

PIPAC-OX: A Phase I study of Oxaliplatin-based Pressurized Intraperitoneal Aerosol Chem...
https://doi.org/10.1158/1078-0432.CCR-20-2152
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research; Kim G, Tan HL et. al.

Nov 5th, 2020 - Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) is a novel, laparoscopic intraperitoneal chemotherapy delivery technique aiming to improve drug distribution and tissue penetration to treat peritoneal metastases. Thus far, PIPAC oxaliplati...

see more →

Guidelines  1 results

Endoscopic resection of superficial gastrointestinal tumors.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4977951
World Journal of Gastroenterology; Marc G, Lopes CV

Aug 13th, 2008 - Therapeutic endoscopy plays a major role in the management of gastrointestinal (GI) neoplasia. Its indications can be generalized into four broad categories; to remove or obliterate neoplastic lesion, to palliate malignant obstruction, or to treat...

see more →

Clinicaltrials.gov  559 results

Tuberous Sclerosis Complex with rare associated findings in the gastrointestinal system...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7682061
BMC Gastroenterology; Reis LB, Konzen D et. al.

Nov 23rd, 2020 - Tuberous Sclerosis Complex (TSC) is a complex and heterogeneous genetic disease that has well-established clinical diagnostic criteria. These criteria do not include gastrointestinal tumors. We report a 45-year-old patient with a clinical and mole...

Prediction of technically difficult endoscopic submucosal dissection for large superfic...
https://doi.org/10.1016/j.gie.2020.11.012
Gastrointestinal Endoscopy; Li B, Shi Q et. al.

Nov 22nd, 2020 - Endoscopic submucosal dissection (ESD) is a promising technique for removing superficial gastrointestinal tumors, but ESD is technically difficult. The aims of this study were to establish a clinical score model for grading technically difficult c...

Imaging Features of Neurofibromatosis Type 1 in the Abdomen and Pelvis.
https://doi.org/10.2214/AJR.19.22283
AJR. American Journal of Roentgenology; Zulfiqar M, Lin M et. al.

Nov 19th, 2020 - OBJECTIVE. Loss of the neurofibromatosis type 1 (NF1) tumor suppressor protein causes uninhibited activation of the RAS oncogene, which leads to tumorigenesis in patients with NF1. This case-based review discusses imaging manifestations of NF1 in ...

Prevalence, diagnosis, and treatment of primary hepatic gastrointestinal stromal tumors.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7596635
World Journal of Gastroenterology; Qian XH, Yan YC et. al.

Nov 12th, 2020 - Gastrointestinal stromal tumors (GIST), which is the most common mesenchymal tumor of the digestive tract, account for 1%-3% of gastrointestinal tumors. Primary stromal tumors outside the gastrointestinal tract are collectively referred to as extr...

PIPAC-OX: A Phase I study of Oxaliplatin-based Pressurized Intraperitoneal Aerosol Chem...
https://doi.org/10.1158/1078-0432.CCR-20-2152
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research; Kim G, Tan HL et. al.

Nov 5th, 2020 - Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) is a novel, laparoscopic intraperitoneal chemotherapy delivery technique aiming to improve drug distribution and tissue penetration to treat peritoneal metastases. Thus far, PIPAC oxaliplati...

see more →

News  15 results

The March of Immunotherapy Continues at ESMO 2020
https://www.staging.medscape.com/viewarticle/937318

Sep 13th, 2020 - The use of immunotherapy for upper gastrointestinal tumors and renal cancer, ALK- and EGFR-targeted agents in non–small cell lunger cancer (NSCLC), and the next step in personalized prostate cancer management will all be subjects of headlining pre...

The March of Immunotherapy Continues at ESMO 2020
https://www.medscape.com/viewarticle/937318

Sep 13th, 2020 - The use of immunotherapy for upper gastrointestinal tumors and renal cancer, ALK- and EGFR-targeted agents in non–small cell lunger cancer (NSCLC), and the next step in personalized prostate cancer management will all be subjects of headlining pre...

Emerging Platform Technology for Cancer: Nuclear Imaging
https://www.medscape.com/viewarticle/901270

Sep 5th, 2018 - Hello. I'm David Kerr, professor of cancer medicine from University of Oxford. I'm never one not to be self-promoting. That's a gentle joke. Most of you are used to me talking about gastrointestinal tumors, but I wanted to stray into other areas b...

Therapeutic endoscopy expands reach to deep GI lesions
https://www.mdedge.com/gihepnews/article/164086/endoscopy/therapeutic-endoscopy-expands-reach-deep-gi-lesions
Michele G. Sullivan, MDedge News

Apr 24th, 2018 - BOSTON – Endoscopic resection of gastrointestinal tumors arising from the muscularis propria is feasible, but the techniques are challenging and require a sure hand with closure techniques. “The main difficulty with these procedures is closure,” M.

FDA approves Lexicon Pharma's carcinoid syndrome diarrhea drug
https://www.reuters.com/article/us-lexicon-pharm-fda/fda-approves-lexicon-pharmas-carcinoid-syndrome-diarrhea-drug-idUSKBN1672MV

Feb 28th, 2017 - (Reuters) - The U.S. Food and Drug Administration said on Tuesday it had approved Lexicon Pharmaceuticals Inc’s oral drug to treat carcinoid syndrome diarrhea, a condition that develops in patients with gastrointestinal tumors. The drug, Xermelo o...

see more →